BioTechniques is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Journal
    • Aims and scope
    • Journal archive
    • Editorial board
    • For authors
    • Your editors: what do we do?

    Follow us on social media

  • Current issue
  • News
    • Latest news
    • Tech news
    • Events news
    • Company news

    Follow us on social media

  • Multimedia
    • Downloadable eBooks
    • Infographics
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • Features
    • Interviews
    • Opinion
    • In Focus
    • Spotlights
    • Companies
    • New products
    • Events

    Follow us on social media

  • Topics
    • Analytical chemistry
      • Biochemistry
      • Bioengineering and biophysics
      • Cancer research
      • Careers and Publishing
      • Cell and tissue biology
      • COVID-19
      • CRISPR
      • Computational biology
    • Diagnostics and preclinical
      • Drug discovery and development
      • Imaging
      • Immunology
      • Lab design and machinery
      • Microbiology
      • Molecular biology
    • Nanomedicine
      • Neuroscience
      • PCR and sequencing
      • Plant and climate science
      • Proteomics
      • Veterinary science
      • Whole-genome studies

    Follow us on social media

  • Become a member
Enhancing protein purification efficiency with advanced filtration solutions WATCH NOW!

eBook: Antibody discovery

19 Jul 2023
Written by Annie Coulson (Digital Editor)
Drug discovery and development Immunology

This eBook rounds up key features from our Spotlight on antibody discovery, including the various techniques and technologies utilized in antibody discovery, how high-throughput flow cytometry can be used for successful discovery campaigns and the emerging role of artificial intelligence in antibody discovery.

DOWNLOAD NOW

Top content

  • Unveiling the Top 10 | BioTechniques Image Competition 2025
  • Be picky: selecting cells with desirable characteristics for further development
  • Hibernating for better health: harnessing the genetic mechanisms underlying hibernation

Related tags

antibody discovery
Previous article Next article

Related articles

phage display
24 APR 2023 DRUG DISCOVERY AND DEVELOPMENT

Developing immunodiagnostics to tackle antimicrobial resistance

5 APR 2023 DRUG DISCOVERY AND DEVELOPMENT

When less is more: reducing immunomodulatory antibody affinity boosts anticancer activity

17 MAR 2023 DRUG DISCOVERY AND DEVELOPMENT

Advanced flow cytometry applications for antibody, small molecule and phenotypic screening

17 MAR 2023 ANALYTICAL CHEMISTRY

Evaluation of complement-dependent cytotoxicity using a streamlined, miniaturized advanced flow cytometry assay

13 MAR 2023 DRUG DISCOVERY AND DEVELOPMENT

No RESP for the wicked: new AI model accelerates antibody discovery

17 MAR 2023 DRUG DISCOVERY AND DEVELOPMENT

Survey: Antibody discovery

  • About BioTechniques
  • Advisory Board
  • Contact Us
  • Advertising
  • Permissions
  • Whitelist Emails
  • Press release policy
  • Accessibility
Contact
Contact Us
Office info

BioTechniques is powered by Taylor & Francis Group

BioTechniques, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom

Impact Factor 2.2 | CiteScore 2.0

  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 BioTechniques